FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA 483 Cites Quality Deficiencies at Indian Drug Plant

[ Price : $8.95]

FDA cites Medispray Laboratories, a finished drug product manufacturer based in Ponda, Goa, India, for significant lapses in its q...

Patient Injured in Intellias Phase 3 nex-z Trial Dies

[ Price : $8.95]

Intellia Therapeutics reports that a patient who experienced liver toxicity after being administered the companys CRISPR-based the...

FDA OKs Darzalex Faspro for Smoldering Multiple Myeloma

[ Price : $8.95]

FDA approves Janssens Darzalex Faspro (daratumumab and hyaluronidase-fihj) for adults with high-risk smoldering multiple myeloma (...

Senate Democrats Caution FDA on Mifepristone Review

[ Price : $8.95]

Senate Democrats say they are worried that FDA and HHS may rely on partisan junk science during its recently announced review of t...

FDA Posts Biohaven Troriluzole Complete Response Letter

[ Price : $8.95]

FDA publicly releases an 11/4 complete response letter issued to Biohaven on its NDA seeking approval for troriluzole to treat spi...

FDA Extends Review of Rhythms Setmelanotide sNDA

[ Price : $8.95]

FDA extends by three months its review of Rhythm Pharmaceuticals supplemental NDA for Imcivree (setmelanotide) and its use in trea...

Baxter Oncology FDA-483 Out

[ Price : $8.95]

FDA releases the form FDA-483 with six observations from an inspection at the Baxter Oncology drug manufacturing facility in Halle...

76 New or Revised Product-Specific Guidances Out

[ Price : $8.95]

FDA publishes 76 new and revised product-specific guidances intended to speed generic drug development and approval.

White House Inks Deals with Lilly and Novo Nordisk

[ Price : $8.95]

The Trump Administration announces new agreements with Eli Lilly and Novo Nordisk to lower U.S. prices for several products, inclu...

6 Additional National Priority Vouchers Awarded

[ Price : $8.95]

FDA announces six additional drugs awarded Commissioners National Priority vouchers.